COMMUNIQUÉS West-GlobeNewswire

New mobile units to drive early breast cancer detection in Alberta
22/09/2025
Alberta Cancer Foundation and Primary Care Alberta bring life-saving breast cancer screening to women in rural and remote communities EDMONTON, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Breast cancer screening is now [...]
Guerbet : Change in General Management
22/09/2025
Change in General Management Villepinte France, September 22nd, 2025 : Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces the appointment of Mr. Jérôme [...]
Guerbet : Evolution de la Direction Générale
22/09/2025
Evolution de la Direction Générale Villepinte, le 22 septembre 2025, 17h45 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce la nomination de [...]
Humanitarian Nonprofit Human Appeal Canada to Host Second Annual Comedy Tour
22/09/2025
Joy and Impact Unleashed as Comedy Tour Funds Critical Relief for Those in Need TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Humanitarian aid nonprofit, Human Appeal Canada , is kicking off their second annual comedy [...]
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
22/09/2025
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG105 1 , a pre-clinical investigational novel compound with broad potential to treat brain health diseases, [...]
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference
22/09/2025
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference Lille, September 22, 2025 – InBrain Pharma, a company specialized in the [...]
Baylor Genetics to Showcase the Expanding Role and Clinical Value of Genetic Testing in Pediatric Neurology at the 2025 Child Neurology Society Annual Meeting
22/09/2025
Company will feature new data on genomic diagnosis in epilepsy, advocate for expanded testing access, and host a symposium on the evolving role of sequencing in patient care HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- [...]
Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management
22/09/2025
Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management ROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Milestone [...]
Celcuity to Present Results from the Pivotal Phase 3 VIKTORIA-1 Trial at the 2025 European Society for Medical Oncology (ESMO) Congress
22/09/2025
MINNEAPOLIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that a late breaking abstract [...]
Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
22/09/2025
Exploring potential partnerships and strategic opportunities for the Company’s stem cell therapy program in Alzheimer’s disease Alzheimer’s disease development program with positive data in successful Phase 1 and Phase [...]
PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes
22/09/2025
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading [...]
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index
22/09/2025
CARLSBAD, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced [...]
WORK Medical Technology Group LTD Partners with Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine to Develop AI-Applications in Healthcare
22/09/2025
Hangzhou, China, Sept. 22, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) [...]
Fierce Biotech names Incyclix Bio a “Fierce 15” Biotech Company of 2025
22/09/2025
RESEARCH TRIANGLE PARK, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, today announced that Fierce Biotech has named it as one of 2025’s Fierce 15 biotechnology companies, designating it as one of the most [...]
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed
22/09/2025
Addition strengthens FemSperm family of products and enables gynecologists to offer complete in-office sperm handling for FemaSeed Intratubal Insemination ATLANTA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ [...]
Yatiri Bio Receives Grant to Advance Proteomics Interoperability in Cancer Research
22/09/2025
SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Yatiri Bio Inc. today announced it has received a grant from the Gates Foundation to launch a one-year project, Proteomics Interoperability , aimed at improving how large- [...]
AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth
22/09/2025
New peer-reviewed article appears in the Journal for ImmunoTherapy of Cancer OCALA, Fla., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the [...]
Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months
22/09/2025
Elraglusib represents a potential back bone therapy in pancreatic cancer with three ongoing trials in combination with current standards of care and novel immunotherapies Recent financing provides extended runway [...]
NetraMark Initiates AI-Driven Collaboration in Glioblastoma Research
22/09/2025
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical [...]

Pages